As of February 2026 GenSight Biologics has a market cap of A$28.61 Million. This makes GenSight Biologics the world's 10154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.